Literature DB >> 20716954

SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.

Yan Jia1, Yunsheng Yang, Shuang Liu, James G Herman, Fengmin Lu, Mingzhou Guo.   

Abstract

SRY-box containing gene 17 (SOX17) was reported to be indispensable for embryonic development and a candidate tumor suppressor gene which antagonizes the canonical WNT/β-catenin signaling pathway in colorectal cancer. In this study, we investigated the function and epigenetic regulation of SOX17 in human hepatocellular carcinoma (HCC). DNA methylation of SOX17 was analyzed in 62 human HCC tissues and HCC cell lines by MSP. A role as a tumor suppressor gene was evaluated by colony formation assay and regulation of WNT/β-catenin signal pathway by SOX17 was determined by IHC and luciferase reporter assay. DNA methylation of the SOX17 promoter region occurs in 82% of HCC tissues and is associated with nuclear accumulation of β-catenin. Restoration of SOX17 inhibits HepG2 colony formation and β-catenin/TCF-dependent transcription with the presence of HMG box in SOX17. In conclusion, SOX17 negatively regulates canonical WNT/β-catenin signaling pathway and inhibits human HCC cells growth, providing an explanation for the loss of expression by epigenetic mechanisms in these tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20716954     DOI: 10.4161/epi.5.8.13104

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  63 in total

1.  Loss of GATA5 expression due to gene promoter methylation induces growth and colony formation of hepatocellular carcinoma cells.

Authors:  Lei Xia; Yan Gong; Aiqun Zhang; Shouwang Cai; Qiang Zeng
Journal:  Oncol Lett       Date:  2015-11-25       Impact factor: 2.967

Review 2.  MicroRNAs: potential regulators of renal development genes that contribute to CAKUT.

Authors:  April K Marrone; Jacqueline Ho
Journal:  Pediatr Nephrol       Date:  2013-09-03       Impact factor: 3.714

3.  Return to youth with Sox17.

Authors:  Akanksha Chhabra; Hanna K A Mikkola
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

4.  Conditional deletion of Sox17 reveals complex effects on uterine adenogenesis and function.

Authors:  Amy Guimarães-Young; Traci Neff; Adam J Dupuy; Michael J Goodheart
Journal:  Dev Biol       Date:  2016-04-19       Impact factor: 3.582

5.  Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.

Authors:  Sui Hu; Baoping Cao; Meiying Zhang; Enqiang Linghu; Qimin Zhan; Malcolm V Brock; James G Herman; Gaoping Mao; Mingzhou Guo
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

6.  Methylation of TFPI-2 is an early event of esophageal carcinogenesis.

Authors:  Yan Jia; Yunsheng Yang; Malcolm V Brock; Baoping Cao; Qimin Zhan; Yazhuo Li; Yuanzi Yu; James G Herman; Mingzhou Guo
Journal:  Epigenomics       Date:  2012-04       Impact factor: 4.778

7.  Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.

Authors:  De-Yuan Fu; Hao-Sheng Tan; Jin-Li Wei; Chang-Ren Zhu; Ji-Xin Jiang; Yu-Xiang Zhu; Feng-Lin Cai; Mei-Hong Chong; Chuan-Li Ren
Journal:  Tumour Biol       Date:  2015-05-14

8.  Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer.

Authors:  Yan Jia; Yunsheng Yang; Malcolm V Brock; Qimin Zhan; James G Herman; Mingzhou Guo
Journal:  J Pathol       Date:  2013-06       Impact factor: 7.996

9.  SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer.

Authors:  Dongtao Yin; Yan Jia; Yuanzi Yu; Malcolm V Brock; James G Herman; Chao Han; Xiaomo Su; Yang Liu; Mingzhou Guo
Journal:  Discov Med       Date:  2012-07       Impact factor: 2.970

10.  Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.

Authors:  Xiaomei Zhang; Yunsheng Yang; Xuefeng Liu; James G Herman; Malcolm V Brock; Julien D F Licchesi; Wen Yue; Xuetao Pei; Mingzhou Guo
Journal:  Epigenetics       Date:  2013-02-28       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.